Wegovy 2.4mg Flextouch Pre-Filled Pen + 4 Needles

Wegovy 2.4 mg FlexTouch Pre-Filled Pen is a prescription injectable medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist specifically developed for long-term chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related health condition such as hypertension, type 2 diabetes, or dyslipidemia. The 2.4 mg dose is typically reached after gradually increasing from lower starter doses to help the body adapt and improve tolerability. This highest weekly dose delivers greater appetite suppression and weight-loss support as part of an ongoing, structured treatment plan. The medication is administered once weekly by subcutaneous injection using the FlexTouch pre-filled pen, and the four included needles support comfortable, accurate self-administration into the abdomen, thigh, or upper arm. Healthcare providers train patients on proper injection technique and timing before starting therapy. Regular clinical monitoring including weight, blood sugar, and overall health assessment helps tailor therapy and ensure optimal outcomes as patients progress through treatment.